SBIOTIC-IT Clinical Monograph & Batch COA
Certified DCGI Formulation Literature (PDF)
SBIOTIC-IT
Ofloxacin 0.75%w/w + Ornidazole 2.00%w/w + Itraconazole 1%w/w + Clobetasol 0.05%w/w
SBIOTIC-IT is a broad-spectrum bactericidal antimicrobial agent exhibiting enhanced pharmacokinetic tissue penetration against susceptible gram-positive and gram-negative pathogens.
Clinical Pharmacology & Therapeutic Profile
Comprehensive therapeutic guidelines for medical practitioners and institutional procurement
Therapeutic Indications
Mechanism of Action (MOA)
Inhibits bacterial DNA gyrase (type II topoisomerase) and topoisomerase IV enzymes required for bacterial DNA replication, transcription, and repair.
Adult: One dose once or twice daily depending on infectious severity. Complete full course to prevent antimicrobial resistance.
Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.
Store in a cool place below 25°C. Do not freeze. Replace cap tightly after use.
WHO-GMP Certified Purity
Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.
Alu-Alu Moisture Barrier
Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.
Exclusive District Monopoly
Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.
Technical Product Specifications
Active Medical Composition
SBIOTIC-IT features Ofloxacin 0.75%w/w + Ornidazole 2.00%w/w + Itraconazole 1%w/w + Clobetasol 0.05%w/w prepared to high pharmaceutical purity standards.
*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.
Apply for Exclusive Marketing Rights of SBIOTIC-IT
Check vacant territory availability in your state or district. Enjoy full marketing kit support, visual aids, and guaranteed zero competitor supply.
Questions Regarding SBIOTIC-IT
What is the therapeutic indication and composition of SBIOTIC-IT?
SBIOTIC-IT contains Ofloxacin 0.75%w/w + Ornidazole 2.00%w/w + Itraconazole 1%w/w + Clobetasol 0.05%w/w indicated for Lower Respiratory Tract Infections as formulated by Sygnus Biotech.
What packaging presentations are available for SBIOTIC-IT?
SBIOTIC-IT is supplied in tamper-evident 15g / 30g Laminated Aluminum Barrier Tube, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.
Is monopoly PCD franchise territory available for SBIOTIC-IT?
Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for SBIOTIC-IT along with promotional visual aids, product cards, and marketing support.
What is the regulatory schedule and minimum order quantity (MOQ)?
SBIOTIC-IT is categorized as Schedule H with an introductory PCD franchise MOQ of 100 units per batch.
Related Formulations in Cream & Ointment
View all Cream & Ointment →
TRIPCEE
Clobetasol 0.05% w/w , Neomycin 0.1% w/w , Miconazole 2% w/w
VIVO+ GEL
Diclofenac Sodium 1% w/v + Linseed Oil 3% w/w + Methyl Salicylate 10% w/w +Capsaicin 0.025% w/w Menthol 5% w/w + Benzyl Alcohol 1% w/w
OXIDINE TOOTH PASTE
Rated 5 out of 5 based on 1 customer rating Pottasium Nitrate + Sodium Monofluorophosphate + Triclosan
ACNEGO ADVANCE CREAM
Hydroquinone 2% w/w + Tretinoin 0.025% w/w + Mometasone Furoate 0.1% w/w